ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (222 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2005.04.030    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier Ltd All rights reserved.

New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Cláudio Viegas, Jr.a, b, Vanderlan S. Bolzanib, Luísa S.B. Pimentelc, Newton G. Castroc, Rafael F. Cabralc, Rodrigo S. Costac, Corinne Floydc, Mônica S. Rochac, Maria C.M. Youngd, Eliezer J. Barreiroa and Carlos A.M. Fragaa, Corresponding Author Contact Information, E-mail The Corresponding Author, E-mail The Corresponding Author

aLaboratório de Avaliação e Síntese, de Substâncias Bioativas (LASSBio), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, CP 68023, 21944-910, Rio de Janeiro, Brazil

bNúcleo de Bioensaios, Biossíntese e Ecofisiologia, de Produtos Naturais (NuBBE), Instituto de Química, Universidade Estadual Paulista ‘Julio de Mesquita Filho’, CP 355, 14801-970, Araraquara, Brazil

cDepartamento de Farmacologia Básica e Clínica, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

dSeção de Bioquímica e Fisiologia de Plantas, Instituto de Botânica, São Paulo, Brazil


Received 4 March 2005; 
revised 13 April 2005; 
accepted 13 April 2005. 
Available online 5 May 2005.

Abstract

Five new piperidine alkaloids were designed from natural (−)-3-O-acetyl-spectaline and (−)-spectaline that were obtained from the flowers of Senna spectabilis (sin. Cassia spectabilis, Leguminosae). Two semi-synthetic analogues (7 and 9) inhibited rat brain acetylcholinesterase, showing IC50 of 7.32 and 15.1 μM, and were 21 and 9.5 times less potent against rat brain butyrylcholinesterase, respectively. Compound 9 (1 mg/kg, ip) was fully efficacious in reverting scopolamine-induced amnesia in mice. The two active compounds (7 and 9) did not show overt toxic effects at the doses tested in vivo.

Graphical abstract

The two new piperidine modified alkaloids 7 and 9 are described as selective acetylcholinesterase inhibitors, IC50 = 7.3 and 15.1 μM, respectively.


Keywords: Piperidine alkaloids; Acetylcholinesterase inhibitors; Alzheimer’s disease; Senna spectabilis

Article Outline

1. Introduction
2. Results and discussion
2.1. Chemistry
2.2. Pharmacology
3. Conclusion
4. Experimental
4.1. Chemistry
4.2. (2R,3R,6S)-2-Methyl-6-(13-oxotetradecyl)piperidin-3-yl acetate (5) and 13-[(2S,5R,6R)-5-hydroxy-6-methylpiperidin-2-yl]tetradecan-2-one (6)
4.3. General procedure for the preparation of hydrochloride derivatives 7–10
4.3.1. (2R,3R,6S)-2-Methyl-6-(13-oxotetradecyl)piperidin-3-yl acetate hydrochloride (7)
4.3.2. 14-[(2S,5R,6R)-5-Hydroxy-6-methylpiperidin-2-yl]tetradecan-2-one hydrochloride (8)
4.3.3. tert-Butyl (2R,3R,6S)-2-methyl-6-(13-oxotetradecyl)piperidin-3-yl carbonate hydrochloride (9)
4.3.4. (2R,3R,6S)-6-(13-Hydroxytetradecyl)-2-methylpiperidin-3-yl acetate hydrochloride (10)
4.3.5. (2R,3R,6S)-1,2-Dimethyl-6-(13-oxotetradecyl)piperidin-3-yl acetate hydroiodide (11)
4.3.6. One-pot preparation of acetyl hydrochloride 7 from natural spectaline (6)
4.4. Pharmacology
4.4.1. Cholinesterase activity assays
4.5. Behavioral studies
4.5.1. Animals and drugs
4.5.2. Passive-avoidance test
4.5.3. Spatial memory test
4.5.4. Evaluation of cholinergic side effects and toxicity
4.5.5. Statistical analysis
Acknowledgements
Supplementary data
References




Corresponding Author Contact InformationCorresponding author. Tel./fax: +55 21 25626503

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.